Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glulisine versus insulin lispro in children and adolescents with type 1 diabetes mellitus
2004-000616-70Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Change in glycated hemoglobin from baseline to endpoint. Started Nov 2004; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2004-000616-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000616-70.